Back to Trades
Other4
Insight Molecular Diagnostics Inc.
IMDX
Total Value
$50.6K
Company Information
- Company Name
- Insight Molecular Diagnostics Inc.
- Ticker Symbol
- IMDX
- CIK
- 0001642380
Insider Information
- Name
- Riggs Josh
- Role
- CEO and President, Director
- Location
- NASHVILLE, TN
DirectorOfficer
Filing Details
- Filing Date
- Mar 30, 2026
- Transaction Date
- Mar 26, 2026
- Accession Number
- 0001493152-26-013571
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Common Stock | 47,170 | — | Exercise | — |
| Mar 26, 2026 | Common Stock | 12,310 | $4.11 | Tax Withholding | $50.6K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Derivative | 47,170 | — | Exercise | — |
Footnotes
- (F1)Represents vesting of restricted stock units ("RSUs") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs vested on the one-year anniversary of the effective date of grant.
- (F2)The reported disposition reflects shares withheld by the Company to cover required tax withholding obligations upon the vesting of the RSUs. The reporting person did not sell any shares.
- (F3)Each RSU has a value equal to one share of common stock. 25% of the RSUs vested on March 26, 2026 and the remaining 75% will vest in equal installments on each of the second-, third- and fourth-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date.